Transarterial infusion chemotherapy using SMANCS with or without embolization in hepatocellular carcinoma: a randomised controlled multicenter phase III trial.
Phase of Trial: Phase III
Latest Information Update: 11 Jan 2012
At a glance
- Drugs Zinostatin stimalamer (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 01 Dec 2009 Primary endpoint 'survival rate' has not been met.
- 01 Dec 2009 Results published in Journal of Hepatology.
- 08 Jun 2009 New trial record.